Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04188366 · ClinicalTrials.gov registry record · NA

Improving Family Engagement in Coordinated Specialty Care for First Episode Psychosis

A NA study, sponsored by Washington State University.

Completed
Registry status
NA
Development phase
50
Enrollment target

NCT04188366: Completed NA study, sponsored by Washington State University.

NCT04188366 is a NA study that has completed, run by Washington State University. The registered enrollment target is 50 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04188366, a NA study, has completed, sponsored by Washington State University.

COMPLETED
Registry status
NA
Development phase
50 participants
Enrollment target

Study Summary

Investigators aim to develop and evaluate a culturally informed family motivational engagement strategy (FAMES) and implementation toolkit for coordinated specialty care (CSC) programs for first episode psychosis. First, 5 family member participants will be recruited into a three-month trial of FAMES and implementation toolkit. The investigators will then conduct a 16-month non-randomized, stepped-wedge trial with 50 family members from 5 CSC programs in community-based mental health clinics.

Primary Outcome

Self-report measure to assess acceptability, a brief measure for family member participant. Items are scored from 1 to 4. Possible total scores range from 8 to 32, with higher scores (\>23) indicating greater satisfaction.

Interventions

  • BEHAVIORAL FAMES
  • BEHAVIORAL Treatment-as-Usual

Trial Details

FieldValue
Enrollment Target 50 participants
Start Date 2021-01-01
Est. Completion 2024-08-31
Phase NA
Washington State University

64 total trials

What the finished NCT04188366 record still lists

NCT04188366 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 50 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower).

The record links to 0 conditions, and to 2 interventions - of which FAMES is the first listed.

NCT04188366 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT04188366 about?

NCT04188366 is a clinical study titled "Improving Family Engagement in Coordinated Specialty Care for First Episode Psychosis". Investigators aim to develop and evaluate a culturally informed family motivational engagement strategy (FAMES) and implementation toolkit for coordinated specialty care (CSC) programs for first episode psychosis. First, 5 family member participants will be recruited into a three-month trial of FAME...

What is the current status of trial NCT04188366?

This trial is currently completed. It is a NA study. The enrollment target is 50 participants. The study started on 2021-01-01. Estimated completion is 2024-08-31.

What interventions are being tested in trial NCT04188366?

The interventions under investigation include: FAMES (BEHAVIORAL), Treatment-as-Usual (BEHAVIORAL).

Who is sponsoring clinical trial NCT04188366?

This trial is sponsored by Washington State University, which has 64 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT04188366's enrollment target sits among peer trials

50 1279th of 2000 higher than 622 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00200889 · 50 participants · Early Phase 1

    Mapping Auricular Vagus Nerve Circuitry

  • NCT00409435 · 50 participants · Phase 2

    A Study of Pyridostigmine in Postural Tachycardia Syndrome

  • NCT01202305 · 50 participants

    The Use of Lymph Node Biopsies to Support HIV Pathogenesis Studies

  • NCT01225913 · 50 participants · Phase 4

    Mechanism(s) of Airflow Limitation During Exacerbation of Asthma

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT04188366, the US trial registry maintained by the National Library of Medicine. NCT04188366 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.